SCHEDULE 13G/A: RTW Investments and Dr. Roderick Wong Disclose 1.3% Passive Stake in 89bio, Inc.
Beneficial Ownership Report
RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 1.3% in 89bio, Inc.'s common stock as of March 31, 2025.
Summary
- RTW Investments, LP and Roderick Wong, M.D. (the "Reporting Persons") have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership in 89bio, Inc.
- As of March 31, 2025, the Reporting Persons collectively beneficially own 1,967,527 shares of 89bio, Inc.'s common stock.
- This represents 1.3% of the total class of securities outstanding.
- The percentage is calculated based on 145,984,182 shares outstanding as of February 24, 2025, as reported in 89bio, Inc.'s Form 10-K filed on February 27, 2025.
- The Reporting Persons share both voting and dispositive power over these 1,967,527 shares.
- The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing (Schedule 13G Amendment) disclosing passive beneficial ownership. It contains no information that would significantly alter the perception of the company's financial health or strategic direction, nor does it indicate any activist intent from the reporting persons.
Positives
- The filing indicates continued passive investment by RTW Investments, LP and Roderick Wong, M.D., suggesting ongoing confidence in 89bio, Inc. as a long-term holding.
Future Outlook
NA
Industry Context
This filing is a routine disclosure by an institutional investor, RTW Investments, LP, and its managing partner, Roderick Wong, M.D., regarding their passive stake in 89bio, Inc. Such filings are common for investment firms that hold significant, but non-controlling, positions in publicly traded companies, particularly in the biotechnology or pharmaceutical sectors where specialized funds often invest.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's passive stake, which can offer some level of confidence in the company's long-term prospects.
- Employees, Customers, Suppliers, Creditors: No direct impact from this beneficial ownership filing.
Key Dates
| Date | Description |
|---|---|
| 2025-02-24 | Date as of which 145,984,182 shares of 89bio, Inc. common stock were reported outstanding in the company's 10-K. |
| 2025-02-27 | Date 89bio, Inc.'s Annual Report on Form 10-K was filed with the SEC, reporting shares outstanding. |
| 2025-03-31 | Date of event which requires filing of this Schedule 13G Amendment No. 2. |
| 2025-05-15 | Filing date of this Schedule 13G Amendment No. 2. |
Keywords
89bio Inc., RTW Investments, Roderick Wong, Schedule 13G, Beneficial Ownership, Common Stock, Passive Investment, SEC Filing, Institutional Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.